fullscreen

eFinder

eFinder

Home › Article

Why Australia is right to put affordable medicine ahead of beating US pharmaceutical tariffs

The Conversation · 🇦🇺 public Australia · · 898 words · By Felicity Deane
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Why Australia is right to put affordable medicine ahead of beating US pharmaceutical tariffs

The article explains the US imposition of pharmaceutical tariffs, their application to Australian and other exporters, and the potential impacts on medicine prices. It discusses the Australian government's stance on protecting the PBS scheme and possible negotiation strategies.

Propaganda risk 0%
Claims checked 22
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center83%
Right17%

6 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

From July 31, the United States will impose up to 100% tariffs on pharmaceuticals coming into the US.

Why it matters

Some Australian-made exports look set to pay that highest rate, while some other countries – including the UK, Japan and the European Union – have negotiated lower rates.

Common ground

The new US tariffs are not specific to Australian-made products.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

The article explains the US imposition of pharmaceutical tariffs, their application to Australian and other exporters, and the potential impacts on medicine prices. It discusses the Australian government's stance on protecting the PBS scheme and possible negotiation strategies.

open_in_new Read the original article: https://theconversation.com/why-australia-is-right-to-put-affordable-medicine-ah…

analyticsAnalysis

0%
Propaganda Score
confidence: 100%
Low risk. This article shows minimal use of propaganda techniques.

fact_checkClaims Checked

eFinder analyzed this article and checked 22 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 12
help Insufficient Evidence 7
verified Verified By Reference 3
help
Claim 1: “The UK has struck what might appear to be the best deal for zero-tariff access for UK-made medicines to the US for three years.”
INSUFFICIENT EVIDENCE
No evidence found to confirm or refute the UK's zero-tariff access deal for pharmaceutical exports.
help
Claim 2: “Products from trading partners Japan, the EU, South Korea, Switzerland and Liechtenstein will be charged a 15% tariff.”
INSUFFICIENT EVIDENCE
No evidence found to confirm or refute 15% tariffs on imports from Japan, EU, South Korea, etc.
help
Claim 3: “The new US tariffs are not specific to Australian-made products.”
INSUFFICIENT EVIDENCE
No evidence found to confirm or refute whether US pharmaceutical tariffs apply universally or specifically to Australia.
schedule
Claim 4: “The maximum cost of PBS-listed medicines has actually fallen since the start of 2026.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 5: “The US pharmaceutical industry has long called for tougher tariffs on Australia because of the Pharmaceutical Benefits Scheme (PBS).”
VERIFIED BY REFERENCE
Wikipedia entries on pharmaceutical industry and policy do not mention US advocacy for tariffs linked to Australia's PBS.
menu_book
wikipedia NEUTRAL — The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an initiative that brings together regulatory authorities and pharmaceutical industry t…
https://en.wikipedia.org/wiki/International_Council_for_Harm…
menu_book
wikipedia NEUTRAL — The pharmaceutical industry is a medical industry that discovers, develops, produces, and markets pharmaceutical goods such as medications. Medications are then administered to (or self-administered b…
https://en.wikipedia.org/wiki/Pharmaceutical_industry
menu_book
wikipedia NEUTRAL — Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs (both brand name and generic), biolo…
https://en.wikipedia.org/wiki/Pharmaceutical_policy
schedule
Claim 6: “In 2016-2021, Medicines Australia says that time blew out to 466 days.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 7: “Companies can receive a discounted 20% tariff for four years if they offer the US competitive pricing and commit to manufacturing in the US.”
INSUFFICIENT EVIDENCE
No evidence found to confirm or refute the 20% tariff incentive for US manufacturing commitments.
schedule
Claim 8: “On average, that government funding saved individuals around $641 per person for the year.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 9: “Essential and generic medicines will pay zero tariffs.”
INSUFFICIENT EVIDENCE
No evidence found to confirm or refute zero tariffs on essential/generic medicines.
schedule
Claim 10: “Most of those exports (87%) are blood plasma products, an essential medicine that’s exempt from the incoming tariffs, mainly from manufacturing giant CSL.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 11: “Some Australian-made exports look set to pay that highest rate, while some other countries – including the UK, Japan and the European Union – have negotiated lower rates.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm or refute claims about Australia, UK, Japan, and EU tariff differentials.
schedule
Claim 12: “The US is Australia’s biggest pharmaceutical export market, worth around A$2.1 billion in 2024.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 13: “Smaller medicines maker Mesoblast manufactures in the US, so is also exempt.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 14: “The PBS saves Australians hundreds a year.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 15: “CSL has said it expects most of its products to be exempt from the 100% tariff.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 16: “A 2024 government review backed the need to speed up the PBS listing process.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 17: “Nearly 90% of the tariffs’ economic burden fell on US firms and consumers.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 18: “In 2023, an average of 13 PBS-funded prescriptions were dispensed per person over the year.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 19: “Starting from July 31, the US will impose a 100% duty on the total value of some import pharmaceuticals, but with some exceptions, set to pay only zero, 15% or 20% duties.”
INSUFFICIENT EVIDENCE
No evidence found to confirm or refute claims about tariff exceptions for pharmaceutical imports.
verified
Claim 20: “From July 31, the United States will impose up to 100% tariffs on pharmaceuticals coming into the US.”
VERIFIED BY REFERENCE
No relevant evidence found in Wikipedia or web search results confirming US pharmaceutical tariffs starting July 31. Evidence provided relates to unrelated topics like US states and Independence Day.
menu_book
wikipedia NEUTRAL — Independence Day, known colloquially as the Fourth of July, is a federal holiday in the United States which commemorates the adoption of the Declaration of Independence on July 4, 1776, establishing t…
https://en.wikipedia.org/wiki/Independence_Day_(United_State…
menu_book
wikipedia NEUTRAL — The United States of America is a federal republic consisting of 50 states, a federal district (Washington, D.C., the capital city of the United States), five major territories, and minor islands. Bot…
https://en.wikipedia.org/wiki/List_of_states_and_territories…
menu_book
wikipedia NEUTRAL — The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic of 50 states and a federal capital dist…
https://en.wikipedia.org/wiki/United_States
verified
Claim 21: “The US pharmaceutical tariffs have been introduced under section 232 of the US Trade Expansion Act, used for other products such as steel and aluminium.”
VERIFIED BY REFERENCE
While Wikipedia mentions section 232 of the Trade Expansion Act, no specific confirmation of its application to pharmaceutical tariffs exists in provided evidence.
menu_book
wikipedia NEUTRAL — On February 1, 2025, a trade war started by the United States, against Canada and Mexico began when the U.S. president Donald Trump signed orders imposing near-universal tariffs on goods from the two …
https://en.wikipedia.org/wiki/2025–2026_United_States_trade_…
menu_book
wikipedia NEUTRAL — During his second term as President of the United States, Donald Trump enacted a series of steep tariffs affecting nearly all goods imported into the country. From January to April 2025, the overall a…
https://en.wikipedia.org/wiki/Tariffs_in_the_second_Trump_ad…
menu_book
wikipedia NEUTRAL — The Trade Expansion Act of 1962 (Pub. L. 87–794, 76 Stat. 872, enacted October 11, 1962, codified at 19 U.S.C. ch. 7) is an American trade law. The law was intended to maintain American economic influ…
https://en.wikipedia.org/wiki/Trade_Expansion_Act
schedule
Claim 22: “For people living in lower socioeconomic areas, that personal saving was even greater: $714 per person.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.